Mode
Text Size
Log in / Sign up
N/A N=523 Randomized Single-blind Diagnostic

Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

HIV Infections

Enrolled (actual)
523
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Total Number of Youth Tested for HIV — 154; 123; 68 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
mLab App (Device); HIV Prevention Information (Behavioral); HIV Home Tests (Device)
Age
Adult · 18+ yrs
Sex
Male
Sponsor
Rebecca Schnall, RN, MPH, PhD
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Number of Youth Tested for HIV
145; 109; 64
PRIMARY
Total Number of Youth Tested for HIV
145; 109; 64
SECONDARY
Total Number of HIV Negative/ Positive Results
161; 189; 88; 0; 0; 0
SECONDARY
Total Number of HIV Negative/ Positive Results
161; 189; 88; 0; 0; 0
SECONDARY
Total Number of Youth Who Link to HIV Care Services
0; 0; 0
SECONDARY
Total Number of Youth Who Link to HIV Care Services
0; 0; 0
SECONDARY
Number of Sexual Partners in the Past 3 Months
2.24; 2.11; 2.43
SECONDARY
Number of Sexual Partners in the Past 3 Months
2.24; 2.11; 2.43
SECONDARY
Number of Condomless Anal Sex Acts
7.01; 8.33; 8.32
SECONDARY
Number of Condomless Anal Sex Acts
7.01; 8.33; 8.32

Summary

The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Health-ITUEM), the proposed project will refine and test a next-generation diagnostic intervention delivered on a mobile platform to improve HIV testing and linkage-to-care outcomes among youth living with and at-risk for HIV. Given the pervasiveness, low cost, and convenience of mobile technology, the investigators hope that the App can help achieve the goals of the National HIV/AIDS Strategy in the US by increasing the number of persons living with HIV who know their serostatus, decreasing HIV-related disparities, and ultimately reducing the risk of HIV transmission and acquisition.

Eligibility Criteria

Inclusion Criteria

  • Birth sex male of any current gender identification;
  • Understand and read English
  • Substantial risk for acquiring HIV infection per CDC guidance (e.g.,YMSM or YTGW and recent anal sex with men)
  • Smartphone ownership
  • Self-report being HIV-negative or unknown status
  • Understand the limitations of the OraQuick test and the mLab App
  • Not having been tested for HIV in the past 6 months (e.g., therefore being somewhat outside of the current CDC testing recommendations for high-risk populations)
  • Not currently taking PrEP
  • Receive a non-reactive result on the rapid HIV test at the Baseline visit

Exclusion Criteria

  • Persons who have a known diagnosis of HIV
  • Persons for whom the investigators determine that participation may be detrimental to the participant or to the study (e.g., severe cognitive deficit).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03803683). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search